0001628280-26-015174
SEC filingNutex Health Inc. announced financial results for FY 2025 and Q4 2025, reporting total revenue of $875.3 million (up 82.4% from 2024), net income attributable to Nutex Health of $70.8 million, and diluted EPS of $10.48. The Board authorized a second $25.0 million stock repurchase program over the next six months.